114 related articles for article (PubMed ID: 10205291)
21. The use of adjusted preoperative CA 19-9 to predict the recurrence of resectable pancreatic cancer.
Kang CM; Kim JY; Choi GH; Kim KS; Choi JS; Lee WJ; Kim BR
J Surg Res; 2007 Jun; 140(1):31-5. PubMed ID: 17418869
[TBL] [Abstract][Full Text] [Related]
22. Adiponectin as a potential differential marker to distinguish pancreatic cancer and chronic pancreatitis.
Chang MC; Chang YT; Su TC; Yang WS; Chen CL; Tien YW; Liang PC; Wei SC; Wong JM
Pancreas; 2007 Jul; 35(1):16-21. PubMed ID: 17575540
[TBL] [Abstract][Full Text] [Related]
23. Serum neopterin levels in patients with HBV infection at various stages.
Demirturk N; Demirdal T; Aktepe OC; Aykin N; Orhan S; Cevik F
Hepatogastroenterology; 2007; 54(75):903-5. PubMed ID: 17591088
[TBL] [Abstract][Full Text] [Related]
24. Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection.
Mildvan D; Spritzler J; Grossberg SE; Fahey JL; Johnston DM; Schock BR; Kagan J
Clin Infect Dis; 2005 Mar; 40(6):853-8. PubMed ID: 15736019
[TBL] [Abstract][Full Text] [Related]
25. Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC.
Muley T; Dienemann H; Ebert W
Anticancer Res; 2003; 23(5b):4085-93. PubMed ID: 14666606
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma.
Koopmann J; Fedarko NS; Jain A; Maitra A; Iacobuzio-Donahue C; Rahman A; Hruban RH; Yeo CJ; Goggins M
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):487-91. PubMed ID: 15006928
[TBL] [Abstract][Full Text] [Related]
27. Neopterin serum levels in pancreatic adenocarcinoma.
Manes G; Spada OA; Rabitti PG; Feola B; Misso S; Minerva A; Uomo G
Int J Pancreatol; 1999 Feb; 25(1):31-7. PubMed ID: 10211419
[TBL] [Abstract][Full Text] [Related]
28. [Accuracy of imaging techniques and tumor markers in the diagnosis of pancreatic cancer].
Clavé P; Boadas J; González-Carro P; Mora J; Pérez C; Martínez A; Roca M; Lluís F; Farré A
Gastroenterol Hepatol; 1999; 22(7):335-41. PubMed ID: 10535205
[TBL] [Abstract][Full Text] [Related]
29. CEACAM1, a novel serum biomarker for pancreatic cancer.
Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD
Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
[TBL] [Abstract][Full Text] [Related]
30. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
31. Neopterin as a marker for activated cell-mediated immunity: application in malignant disease.
Reibnegger G; Fuchs D; Fuith LC; Hausen A; Werner ER; Werner-Felmayer G; Wachter H
Cancer Detect Prev; 1991; 15(6):483-90. PubMed ID: 1782638
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of neopterin for prognosis and follow-up in ovarian cancer.
Reibnegger G; Hetzel H; Fuchs D; Fuith LC; Hausen A; Werner ER; Wachter H
Cancer Res; 1987 Sep; 47(18):4977-81. PubMed ID: 3621185
[TBL] [Abstract][Full Text] [Related]
33. [Ca 19-9 antigen in differentiation of pancreatic inflammatory and neoplastic tumors].
Markocka-Maczka K
Wiad Lek; 2003; 56(11-12):537-40. PubMed ID: 15058160
[TBL] [Abstract][Full Text] [Related]
34. Significance of the expression of the growth factor pleiotrophin in pancreatic cancer patients.
Klomp HJ; Zernial O; Flachmann S; Wellstein A; Juhl H
Clin Cancer Res; 2002 Mar; 8(3):823-7. PubMed ID: 11895915
[TBL] [Abstract][Full Text] [Related]
35. Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer.
Waraya M; Yamashita K; Katagiri H; Ishii K; Takahashi Y; Furuta K; Watanabe M
Ann Surg Oncol; 2009 May; 16(5):1231-40. PubMed ID: 19263172
[TBL] [Abstract][Full Text] [Related]
36. Cervical intraepithelial neoplasia is not associated with elevated serum neopterin levels.
Strickler HD; Escoffery C; Rattray C; Fuchs D; Wachter H; Manns A; Schiffman MH; Cranston B; Hanchard B; Blattner WA
Cancer Epidemiol Biomarkers Prev; 1995; 4(3):295-8. PubMed ID: 7606206
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of CA 125 and TPS levels after 3 chemotherapy courses in ovarian cancer patients.
van Dalen A; Favier J; Burges A; Hasholzner U; de Bruijn HW; Dobler-Girdziunaite D; Dombi VH; Fink D; Giai M; McGing P; Harlozinska A; Kainz C; Markowska J; Molina R; Sturgeon C; Bowman A; Einarsson R
Gynecol Oncol; 2000 Dec; 79(3):444-50. PubMed ID: 11104617
[TBL] [Abstract][Full Text] [Related]
38. [The prognostic value of CA 19-9 in the preoperative work-up of pancreatic cancer patients].
Grinbaum R; Nissan A; Beglaibter N; Cohen T; Peretz T; Freund HR
Harefuah; 2006 Nov; 145(11):793-4, 863. PubMed ID: 17183947
[TBL] [Abstract][Full Text] [Related]
39. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
[TBL] [Abstract][Full Text] [Related]
40. Serum neopterin levels in haematological malignancies.
Caenazzo A; Pietrogrande F; Sgarabotto D; Dazzi F; Sartori D; Vattamattathil KP; Girolami A
Haematologica; 1993; 78(4):225-9. PubMed ID: 8294054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
